Air Methods Corp (NASDAQ:AIRM) has been upgraded to Hold in a statement by Zacks Investment Research earlier today.
- Updated: September 27, 2016
Zacks Investment Research has upgraded Air Methods Corp (NASDAQ:AIRM) to Hold in a statement released on 9/27/2016.
On 08/05/2016, Oppenheimer released a statement for Air Methods Corp (NASDAQ:AIRM) bumped down the target price from $58.00 to $50.00 that suggested an upside of 0.54%.
Boasting a price of $31.82, Air Methods Corp (NASDAQ:AIRM) traded 0.47% higher on the day. With the last stock price close down -9.86% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time. The company has recorded a 50-day moving average of $33.04 and a 200-day moving average of $35.30. 341,055 shares of AIRM traded hands, down from an average trading volume of 432,120
Recent Performance Chart
Air Methods Corp has 52 week low of $30.57 and a 52 week high of $46.50 with a PE ratio of 10.85 and has a market capitalization of $0.
Brief Synopsis On Air Methods Corp (NASDAQ:AIRM)
Air Methods Corporation is engaged in providing air medical emergency transport services and systems throughout the United States. The Company's segments include Air Medical Services (AMS), Tourism and United Rotorcraft (UR) Division. The Company's AMS segment provides air medical transportation services to the general population as an independent service and to hospitals or other institutions under exclusive operating agreements. It offers services, including aircraft operation and maintenance, medical care, dispatch and communications, and medical billing and collection. The Tourism segment provides helicopter tours and charter flights, primarily focusing on Grand Canyon and Hawaiian Island tours. The United Rotorcraft (UR) Division segment designs, manufactures, and installs aircraft medical interiors and other aerospace and medical transport products for domestic and international customers.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.